Serum Glutamic Pyruvic Transaminase (SGPT)

I am a returning customer
I want this for my family

Product Description

Serum Glutamic Pyruvic Transaminase (SGPT) is an enzyme that is normally found in the liver. SGPT is also called as Alanine Transaminse (ALT). It is an enzyme that is normally present in liver and heart cells. SGPT is released into blood when there is liver problem or heart is damaged. The blood SGPT levels are thus elevated with liver damage or with an insult to the heart. Some medications can also raise SGPT levels.

Significantly elevated levels of SGPT often suggest the existence of other medical problems such as viral hepatitis, diabetes, congestive heart failure, liver damage, bile duct problems or myopathy. SGPT is yet another important enzymes in amino acid metabolism and an important test to measure liver health. In fact SGPT is also more specific to the liver than SGOT. SGPT is usually used as a Liver Function Test i.e to detect liver problem and damage. SGPT is almost always ordered along with SGOT. Symptoms of a liver disorder usually include weakness, fatigue, loss of appetite, abdominal swelling, pain, jaundice etc.
SGPT values are often compared to the results of other tests such as alkaline phosphatase (ALP), total protein and bilirubin.

SGPT helps to determine:

  • Which form of liver disease is present.
  • Treatment regimen for individuals who have liver disease
  • It helps to see if the treatment is working.
  • SGPT may be ordered either by itself or along with other tests.
SpecimenSerum (Blood)
Related TestsSGOT; Alkaline Phosphotase; Gamma-Glutamyl Transferase; Bilirubin; Liver Panel; Albumin, Total Protein
Schedule Visit
Opt for Metropolis, The Pathology Specialist
The Metropolis Edge

The Metropolis Edge

  • Report trusted by Doctors.
  • Global & National Quality Accreditations – CAP (USA) and NABL , Govt. of India.
  • Guaranteed error free diagnosis.
  • Bar Coded and automated process. No room for manual errors.
  • Specific normal range for Indian population built from 33 years of experience.
  • Sample collection from home/office.
Metropolis: Experience + Expertise

Metropolis: Experience + Expertise

Over the past 3 decades we have earned the respect of doctors and patients. Today we conduct over 30 million tests annually with accuracy each year. Our repertoire extends over 4500 tests and over 100 different technologies. Our customer care is available round the clock for any queries that you may have.

Reach out to our Counsellors
Comprehensive Analysis Of Your Health
Save tax on the Preventive health check-ups up to Rs. 5000, under section 80D of Income Tax Act, 1961
We are Metropolis - Your Pathology Specialist

Metropolis is one of the leading diagnostics companies in India, by revenue, as of March 31, 2018 (Source: Frost & Sullivan). With operations across India, Africa, South Asia and Middle East.

Our globally accredited clinical laboratories deliver accurate and timely test results. We offer a comprehensive range of clinical laboratory tests and profiles which are used in prediction, early detection, diagnostic screening, confirmation and monitoring of diseases.


  • Delivering diagnostic services since 1980
  • Network of 100+ clinical labs & 1100+ patient touch points
  • Qualified team of phlebotomists for Home collection services


  • Certified NABL and CAP accredited labs
  • Wide range of 4000+ tests & profiles
  • Convenience of home collection service


Metropolis Healthcare Limited is proposing subject to applicable statutory or regulatory requirements, receipt of requisite approvals, market conditions and other considerations to undertake an initial public offering of its equity shares and has filed a draft red herring prospectus dated September 27, 2018 (“DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the website of the SEBI at, BSE Limited at, National Stock Exchange of India Limited at and the websites of Book Running Lead Managers at,,, and Any potential investors should note that investment in equity shares involves a high degree of risk and for details relating to same, please refer to the DRHP including the section “Risk Factors” of the DRHP. Potential investors should not rely on the DRHP filed with the SEBI for making any investment decision.


Scroll Up